GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 420
Submission : 1960-12-07
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 420
Submission : 1960-12-07
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : CANASA
Dosage Form : SUPPOSITORY; RECTAL
Application Number : 21252
Country : US
Patented : No
Drug : MESALAMINE
Dosage Form : SUPPOSITORY; RECTAL
Application Number : 210509
Country : US
Patented : No
Drug : PROMETHEGAN
Dosage Form : SUPPOSITORY; RECTAL
Application Number : 87165
Country : US
Patented : No
Drug : PROMETHAZINE HYDROCHLORIDE
Dosage Form : SUPPOSITORY; RECTAL
Application Number : 40428
Country : US
Patented : No
Drug : MESALAMINE
Dosage Form : SUPPOSITORY; RECTAL
Application Number : 202065
Country : US
Patented : No
Drug : MESALAMINE
Dosage Form : SUPPOSITORY; RECTAL
Application Number : 204354
Country : US
Patented : No
Drug : INDOMETHACIN
Dosage Form : SUPPOSITORY; RECTAL
Application Number : 216184
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
Application : Thickeners and Stabilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
Application : Thickeners and Stabilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
Application : Thickeners and Stabilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
Application : Thickeners and Stabilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
Application : Solubilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
Application : Solubilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
Application : Solubilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
Application : Solubilizers
Excipient Details : Hard fat for suppository matrix, viscosity enhancer
MARKET PLACE
Reply
16 Jun 2020
LOOKING FOR A SUPPLIER?